Afimmune Limited
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 30, 2027The maintenance fee for Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same (US 10,363,235) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same (US 10,570,083) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,813,903 | Compositions Comprising 15-HEPE and Methods of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 9,670,126 | Methods of making 15-hydroxy fatty acid derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 10,363,235 | Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,047,033 | Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 12,017,986 | Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 10,570,083 | Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 9,855,238 | Compositions Comprising 15-HEPE and Methods of Using the Same In force · High confidence | In force | High confidence | |
| US 10,231,945 | Compositions Comprising 15-HEPE and Methods of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 12,274,685 | Compositions Comprising 15-HEPE and Methods of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 12,076,304 | Compositions Comprising 15-HEPE and Methods of Treating or Preventing Hematologic Disorders, And/Or Related Diseases In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 2 patents in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 5 abandoned · 7 no status recorded